InvestorsHub Logo
Followers 467
Posts 26918
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 6287

Wednesday, 09/11/2013 9:57:46 AM

Wednesday, September 11, 2013 9:57:46 AM

Post# of 6485
7:32AM Insmed announces two patent allowances in the U.S. and Europe (INSM) 15.14 : Co announces two important patent allowances in the U.S. and Europe that strengthen the Company's global patent portfolio. Insmed is focused on the development and commercialization of ARIKACE for at least two identified orphan patient populations: cystic fibrosis patients with Pseudomonas aeruginosa lung infections and patients with non-tuberculous mycobacteria lung infections.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News